FR2509730A1 - Nouveaux phenols o-halogenes et o-substitues par un heterocycle, leur procede de preparation, medicaments les contenant, notamment anti-hypertenseurs, et nouveaux intermediaires de synthese - Google Patents
Nouveaux phenols o-halogenes et o-substitues par un heterocycle, leur procede de preparation, medicaments les contenant, notamment anti-hypertenseurs, et nouveaux intermediaires de synthese Download PDFInfo
- Publication number
- FR2509730A1 FR2509730A1 FR8114011A FR8114011A FR2509730A1 FR 2509730 A1 FR2509730 A1 FR 2509730A1 FR 8114011 A FR8114011 A FR 8114011A FR 8114011 A FR8114011 A FR 8114011A FR 2509730 A1 FR2509730 A1 FR 2509730A1
- Authority
- FR
- France
- Prior art keywords
- formula
- tetrahydro
- tert
- butyl
- imidazolinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 21
- 238000002360 preparation method Methods 0.000 title claims description 7
- 239000000543 intermediate Substances 0.000 title claims description 6
- 239000003814 drug Substances 0.000 title claims description 3
- 150000002989 phenols Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 35
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 5
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 25
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 23
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 21
- -1 4-tert-butyl 6-bromophenol hydrochloride Chemical compound 0.000 claims description 18
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 15
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 10
- LRANPJDWHYRCER-UHFFFAOYSA-N 1,2-diazepine Chemical compound N1C=CC=CC=N1 LRANPJDWHYRCER-UHFFFAOYSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 9
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 5
- 239000004280 Sodium formate Substances 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 235000019253 formic acid Nutrition 0.000 claims description 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 5
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 claims description 5
- 235000019254 sodium formate Nutrition 0.000 claims description 5
- MHCVCKDNQYMGEX-UHFFFAOYSA-N 1,1'-biphenyl;phenoxybenzene Chemical group C1=CC=CC=C1C1=CC=CC=C1.C=1C=CC=CC=1OC1=CC=CC=C1 MHCVCKDNQYMGEX-UHFFFAOYSA-N 0.000 claims description 4
- 206010020772 Hypertension Diseases 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- FFRLMQPMGIMHHQ-UHFFFAOYSA-N 2-bromo-4-tert-butylphenol Chemical compound CC(C)(C)C1=CC=C(O)C(Br)=C1 FFRLMQPMGIMHHQ-UHFFFAOYSA-N 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 239000004312 hexamethylene tetramine Substances 0.000 claims description 3
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- JSZOAYXJRCEYSX-UHFFFAOYSA-N 1-nitropropane Chemical compound CCC[N+]([O-])=O JSZOAYXJRCEYSX-UHFFFAOYSA-N 0.000 claims description 2
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 claims description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 2
- 150000004985 diamines Chemical class 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 3
- IDXKTTNFXPPXJY-UHFFFAOYSA-N pyrimidin-1-ium;chloride Chemical compound Cl.C1=CN=CN=C1 IDXKTTNFXPPXJY-UHFFFAOYSA-N 0.000 claims 2
- NZXPVOQYYCPOOD-UHFFFAOYSA-N 2-bromophenol hydrobromide Chemical compound Br.BrC1=CC=CC=C1O NZXPVOQYYCPOOD-UHFFFAOYSA-N 0.000 claims 1
- NXRYHAPCROJRPU-UHFFFAOYSA-N 2-iodo-4-(2-methylpropyl)phenol Chemical compound CC(C)CC1=CC=C(O)C(I)=C1 NXRYHAPCROJRPU-UHFFFAOYSA-N 0.000 claims 1
- IZWIVVFDCOVKAF-UHFFFAOYSA-N 4-cyclohexyl-2-iodophenol Chemical compound C1(CCCCC1)C1=CC=C(C(=C1)I)O IZWIVVFDCOVKAF-UHFFFAOYSA-N 0.000 claims 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 52
- 239000013078 crystal Substances 0.000 description 36
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 22
- 230000008018 melting Effects 0.000 description 21
- 238000002844 melting Methods 0.000 description 21
- 238000003756 stirring Methods 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- GJYCVCVHRSWLNY-UHFFFAOYSA-N 2-butylphenol Chemical compound CCCCC1=CC=CC=C1O GJYCVCVHRSWLNY-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 229960000583 acetic acid Drugs 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 7
- 229910052794 bromium Inorganic materials 0.000 description 7
- 239000012362 glacial acetic acid Substances 0.000 description 7
- GDEHXPCZWFXRKC-UHFFFAOYSA-N 4-(2-methylpropyl)phenol Chemical compound CC(C)CC1=CC=C(O)C=C1 GDEHXPCZWFXRKC-UHFFFAOYSA-N 0.000 description 6
- OAHMVZYHIJQTQC-UHFFFAOYSA-N 4-cyclohexylphenol Chemical compound C1=CC(O)=CC=C1C1CCCCC1 OAHMVZYHIJQTQC-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- QZRGKCOWNLSUDK-UHFFFAOYSA-N Iodochlorine Chemical compound ICl QZRGKCOWNLSUDK-UHFFFAOYSA-N 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- QHPQWRBYOIRBIT-UHFFFAOYSA-N 4-tert-butylphenol Chemical compound CC(C)(C)C1=CC=C(O)C=C1 QHPQWRBYOIRBIT-UHFFFAOYSA-N 0.000 description 4
- RKXNMODLNNMIDZ-UHFFFAOYSA-N 5-butyl-2-methoxybenzonitrile Chemical compound CCCCc1ccc(OC)c(c1)C#N RKXNMODLNNMIDZ-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- ACEWDEPYJXWCLQ-UHFFFAOYSA-N 2-(chloromethyl)-4-cyclohexyl-1-methoxybenzene Chemical compound C1=C(CCl)C(OC)=CC=C1C1CCCCC1 ACEWDEPYJXWCLQ-UHFFFAOYSA-N 0.000 description 3
- NQCJZTNSJLVEIJ-UHFFFAOYSA-N 5-butyl-2-methoxybenzaldehyde Chemical compound CCCCC1=CC=C(OC)C(C=O)=C1 NQCJZTNSJLVEIJ-UHFFFAOYSA-N 0.000 description 3
- SNTGTTYQCYSKCV-UHFFFAOYSA-N 5-cyclohexyl-2-methoxybenzonitrile Chemical compound C1=C(C#N)C(OC)=CC=C1C1CCCCC1 SNTGTTYQCYSKCV-UHFFFAOYSA-N 0.000 description 3
- JZUQXZYDCGGNOD-UHFFFAOYSA-N Br.C(C(C)C)C1=CC=C(C(=C1)Br)O Chemical compound Br.C(C(C)C)C1=CC=C(C(=C1)Br)O JZUQXZYDCGGNOD-UHFFFAOYSA-N 0.000 description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000035488 systolic blood pressure Effects 0.000 description 3
- 238000005292 vacuum distillation Methods 0.000 description 3
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N 2-(2-methylpropyl)phenol Chemical compound CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- ABMULKFGWTYIIK-UHFFFAOYSA-N 2-hexylphenol Chemical compound CCCCCCC1=CC=CC=C1O ABMULKFGWTYIIK-UHFFFAOYSA-N 0.000 description 2
- KQDJTBPASNJQFQ-UHFFFAOYSA-N 2-iodophenol Chemical compound OC1=CC=CC=C1I KQDJTBPASNJQFQ-UHFFFAOYSA-N 0.000 description 2
- OEOLKNMIIVPMNL-UHFFFAOYSA-N 2-methoxy-5-(2-methylpropyl)benzaldehyde Chemical compound COC1=CC=C(CC(C)C)C=C1C=O OEOLKNMIIVPMNL-UHFFFAOYSA-N 0.000 description 2
- ATPULYRKETXISZ-UHFFFAOYSA-N 2-methoxy-5-(2-methylpropyl)benzonitrile Chemical compound COC1=CC=C(CC(C)C)C=C1C#N ATPULYRKETXISZ-UHFFFAOYSA-N 0.000 description 2
- FGLBSLMDCBOPQK-UHFFFAOYSA-N 2-nitropropane Chemical compound CC(C)[N+]([O-])=O FGLBSLMDCBOPQK-UHFFFAOYSA-N 0.000 description 2
- DTNQNHHVSJPDSG-UHFFFAOYSA-N 4-tert-butyl-2-iodophenol Chemical compound CC(C)(C)C1=CC=C(O)C(I)=C1 DTNQNHHVSJPDSG-UHFFFAOYSA-N 0.000 description 2
- GNJARJFZBGIEPD-UHFFFAOYSA-N 5-cyclohexyl-2-methoxybenzaldehyde Chemical compound C1=C(C=O)C(OC)=CC=C1C1CCCCC1 GNJARJFZBGIEPD-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LPWXSOPQCSHMGY-UHFFFAOYSA-N Cl.C1(CCCCC1)C1=CC=C(C(=C1)I)O Chemical compound Cl.C1(CCCCC1)C1=CC=C(C(=C1)I)O LPWXSOPQCSHMGY-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- BATMYWDOUUWCJE-UHFFFAOYSA-N pyrimidin-1-ium;bromide Chemical compound Br.C1=CN=CN=C1 BATMYWDOUUWCJE-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 101150035983 str1 gene Proteins 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical group C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 description 1
- YJJPDZNZPQKZGC-UHFFFAOYSA-N 1-cyclohexyl-4-methoxybenzene Chemical compound C1=CC(OC)=CC=C1C1CCCCC1 YJJPDZNZPQKZGC-UHFFFAOYSA-N 0.000 description 1
- HQLRIVTWEZSDRG-UHFFFAOYSA-N 2-(chloromethyl)-1-methoxy-4-(2-methylpropyl)benzene Chemical compound COC1=CC=C(CC(C)C)C=C1CCl HQLRIVTWEZSDRG-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical class NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- GKTDOOAXYAVDML-UHFFFAOYSA-N 2-bromo-4-(2-methylpropyl)phenol Chemical compound CC(C)CC1=CC=C(O)C(Br)=C1 GKTDOOAXYAVDML-UHFFFAOYSA-N 0.000 description 1
- DSYPBKQKCSJRHB-UHFFFAOYSA-N 2-bromo-4-cyclohexylphenol Chemical compound C1=C(Br)C(O)=CC=C1C1CCCCC1 DSYPBKQKCSJRHB-UHFFFAOYSA-N 0.000 description 1
- VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical compound OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 description 1
- IHXSQPBLWZQFSZ-UHFFFAOYSA-N 2-butyl-6-iodophenol Chemical compound CCCCC1=CC=CC(I)=C1O IHXSQPBLWZQFSZ-UHFFFAOYSA-N 0.000 description 1
- CQKKTUCVEOBIBW-UHFFFAOYSA-N 2-butylbenzonitrile Chemical compound CCCCC1=CC=CC=C1C#N CQKKTUCVEOBIBW-UHFFFAOYSA-N 0.000 description 1
- VUGCKXJUVZGJRZ-UHFFFAOYSA-N 2-chloro-4-(2-methylpropyl)phenol Chemical compound CC(C)CC1=CC=C(O)C(Cl)=C1 VUGCKXJUVZGJRZ-UHFFFAOYSA-N 0.000 description 1
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 1
- UFLRBXVWDKCBMB-UHFFFAOYSA-N 2-iodophenol hydrochloride Chemical compound Cl.IC1=C(C=CC=C1)O UFLRBXVWDKCBMB-UHFFFAOYSA-N 0.000 description 1
- IIVWHGMLFGNMOW-UHFFFAOYSA-N 2-methylpropane Chemical compound C[C](C)C IIVWHGMLFGNMOW-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- CBBSQHHHRWGZFZ-UHFFFAOYSA-N 4-butylphenol Chemical compound [CH2]CCCC1=CC=C(O)C=C1 CBBSQHHHRWGZFZ-UHFFFAOYSA-N 0.000 description 1
- ZWEIHAXNAVZWMQ-UHFFFAOYSA-N 4-tert-butyl-2-(chloromethyl)-1-methoxybenzene Chemical compound COC1=CC=C(C(C)(C)C)C=C1CCl ZWEIHAXNAVZWMQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- RTIFOGJTFQKUHD-UHFFFAOYSA-N Br.C1(CCCCC1)C1=CC=C(C(=C1)Br)O Chemical compound Br.C1(CCCCC1)C1=CC=C(C(=C1)Br)O RTIFOGJTFQKUHD-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- ULEPSVFQTQJPPI-UHFFFAOYSA-N Cl.C(C(C)C)C1=CC=C(C(=C1)Cl)O Chemical compound Cl.C(C(C)C)C1=CC=C(C(=C1)Cl)O ULEPSVFQTQJPPI-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- BURFGKSKQABJMH-UHFFFAOYSA-N O.Cl.C(C(C)C)C1=CC=C(C(=C1)I)O Chemical compound O.Cl.C(C(C)C)C1=CC=C(C(=C1)I)O BURFGKSKQABJMH-UHFFFAOYSA-N 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 238000006007 Sommelet synthesis reaction Methods 0.000 description 1
- FPWNQPQTICPCOM-UHFFFAOYSA-N acetonitrile;propan-2-ol Chemical compound CC#N.CC(C)O FPWNQPQTICPCOM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000007265 chloromethylation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000926 not very toxic Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- DHHVAGZRUROJKS-UHFFFAOYSA-N phentermine Chemical compound CC(C)(N)CC1=CC=CC=C1 DHHVAGZRUROJKS-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- UMFCIIBZHQXRCJ-NSCUHMNNSA-N trans-anol Chemical compound C\C=C\C1=CC=C(O)C=C1 UMFCIIBZHQXRCJ-NSCUHMNNSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
- C07C45/562—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
- C07C45/565—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom by reaction with hexamethylene-tetramine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/56—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups
- C07C47/565—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups all hydroxy groups bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/56—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups
- C07C47/57—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8114011A FR2509730A1 (fr) | 1981-07-17 | 1981-07-17 | Nouveaux phenols o-halogenes et o-substitues par un heterocycle, leur procede de preparation, medicaments les contenant, notamment anti-hypertenseurs, et nouveaux intermediaires de synthese |
| JP57502218A JPS58501127A (ja) | 1981-07-17 | 1982-07-19 | 置換基の1つが複素環基である新規ジ−オルト置換フェノ−ル,それらの製造方法,それらの化合物を含む特に抗−高血圧性剤,薬物および新規合成中間体 |
| AU87316/82A AU8731682A (en) | 1981-07-17 | 1982-07-19 | Anti-hypertensor, heterocyclically di-orthosubstituted phenols |
| MC82FR8200120D MC1517A1 (fr) | 1981-07-17 | 1982-07-19 | Nouveaux phenols di-orthosubstitues dont une des substitutions est un heterocycle,leur procede de preparation,medicaments les contenant notamment anti-hypertenseurs et nouveaux intermediaires de synthese |
| EP82401339A EP0070779A3 (fr) | 1981-07-17 | 1982-07-19 | Nouveaux phénols di-ortho substitués dont une des substitutions est un hétérocycle, leur procédé de préparation, médicaments les contenant, notamment anti-hypertenseurs et nouveaux intermédiaires de synthèse |
| PCT/FR1982/000120 WO1983000333A1 (fr) | 1981-07-17 | 1982-07-19 | Phenols di-orthosubstitues a substitution heterocyclique, anti-hypertenseurs. |
| DK119783A DK119783A (da) | 1981-07-17 | 1983-03-15 | Di-orthosubstituerede phenoler, hvori en af substituenterne er en heterocyclisk gruppe, fremgangsmaade til fremstilling deraf samt midler indeholdende forbindelserne |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8114011A FR2509730A1 (fr) | 1981-07-17 | 1981-07-17 | Nouveaux phenols o-halogenes et o-substitues par un heterocycle, leur procede de preparation, medicaments les contenant, notamment anti-hypertenseurs, et nouveaux intermediaires de synthese |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2509730A1 true FR2509730A1 (fr) | 1983-01-21 |
| FR2509730B1 FR2509730B1 (enExample) | 1984-01-06 |
Family
ID=9260633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8114011A Granted FR2509730A1 (fr) | 1981-07-17 | 1981-07-17 | Nouveaux phenols o-halogenes et o-substitues par un heterocycle, leur procede de preparation, medicaments les contenant, notamment anti-hypertenseurs, et nouveaux intermediaires de synthese |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0070779A3 (enExample) |
| JP (1) | JPS58501127A (enExample) |
| AU (1) | AU8731682A (enExample) |
| DK (1) | DK119783A (enExample) |
| FR (1) | FR2509730A1 (enExample) |
| MC (1) | MC1517A1 (enExample) |
| WO (1) | WO1983000333A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3332780A1 (de) * | 1983-09-10 | 1985-03-28 | Hoechst Ag, 6230 Frankfurt | 6-sulfoxyphenolderivate, ihre herstellung und ihre verwendung als cytoprotekiva |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB591683A (en) * | 1945-05-02 | 1947-08-26 | Boots Pure Drug Co Ltd | Improvements in and relating to the manufacture of heterocyclic compounds |
| GB614032A (en) * | 1946-07-01 | 1948-12-08 | Boots Pure Drug Co Ltd | Improvements in the manufacture of heterocyclic compounds |
| FR2081505A1 (enExample) * | 1970-02-12 | 1971-12-03 | American Home Prod |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54145631A (en) * | 1978-04-05 | 1979-11-14 | Ube Ind Ltd | Preparation of 2-cyanophenol derivative |
| JPS54145632A (en) * | 1978-04-05 | 1979-11-14 | Ube Ind Ltd | Preparation of 2-cyanophenol derivative |
| JPS6039349B2 (ja) * | 1979-06-20 | 1985-09-05 | 宇部興産株式会社 | 2−シアノフエノ−ル誘導体の製法 |
-
1981
- 1981-07-17 FR FR8114011A patent/FR2509730A1/fr active Granted
-
1982
- 1982-07-19 MC MC82FR8200120D patent/MC1517A1/xx unknown
- 1982-07-19 JP JP57502218A patent/JPS58501127A/ja active Pending
- 1982-07-19 EP EP82401339A patent/EP0070779A3/fr not_active Withdrawn
- 1982-07-19 AU AU87316/82A patent/AU8731682A/en not_active Abandoned
- 1982-07-19 WO PCT/FR1982/000120 patent/WO1983000333A1/fr not_active Ceased
-
1983
- 1983-03-15 DK DK119783A patent/DK119783A/da not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB591683A (en) * | 1945-05-02 | 1947-08-26 | Boots Pure Drug Co Ltd | Improvements in and relating to the manufacture of heterocyclic compounds |
| GB614032A (en) * | 1946-07-01 | 1948-12-08 | Boots Pure Drug Co Ltd | Improvements in the manufacture of heterocyclic compounds |
| FR2081505A1 (enExample) * | 1970-02-12 | 1971-12-03 | American Home Prod |
Also Published As
| Publication number | Publication date |
|---|---|
| DK119783D0 (da) | 1983-03-15 |
| JPS58501127A (ja) | 1983-07-14 |
| DK119783A (da) | 1983-03-15 |
| FR2509730B1 (enExample) | 1984-01-06 |
| EP0070779A3 (fr) | 1983-06-22 |
| WO1983000333A1 (fr) | 1983-02-03 |
| EP0070779A2 (fr) | 1983-01-26 |
| MC1517A1 (fr) | 1984-02-10 |
| AU8731682A (en) | 1983-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH05208957A (ja) | 新規r−及びs−カルバゾール誘導体 | |
| EP0110781B1 (fr) | (Amino-2 éthyl)-6 benzoxazolinones substituées, leur préparation et une composition pharmaceutique les contenant | |
| WO1993020045A1 (fr) | Derives d'indane-1,3-dione et d'indane-1,2,3-trione, leurs procedes de preparation et leur application en therapeutique | |
| US4255575A (en) | 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives | |
| EP0301936B1 (fr) | Dérivés de pipéridine, leur préparation et leur application en thérapeutique | |
| CH630606A5 (en) | Phenylamidine derivatives useful especially in therapeutics | |
| FR2547822A1 (fr) | Acylpiperazinoquinazolines substituees utiles comme medicaments et procede pour leur preparation | |
| EP0089894A1 (fr) | (Benzimidazolyl-1)-1,N-((hydroxy-4 méthoxy-3 phényl)-2 hydroxy-2 éthyl) amino-3 butane et ses sels et hydrates à activité bêta-adrénergique, leurs applications thérapeutiques, et procédé pour les préparer | |
| CH449652A (fr) | Procédé de préparation de nouvelles hydroxydiamines | |
| FR2509730A1 (fr) | Nouveaux phenols o-halogenes et o-substitues par un heterocycle, leur procede de preparation, medicaments les contenant, notamment anti-hypertenseurs, et nouveaux intermediaires de synthese | |
| EP0115714A1 (fr) | Composition pharmaceutique à action psychotrope dopanimergique | |
| FR2600647A1 (fr) | Derives de la glycine | |
| EP0005091B1 (fr) | Nouvelles pipérazines monosubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant | |
| US4847403A (en) | 2-Isopropyl-2-(2-methylphenyl)-5-(N-methyl-N-homoveratrylamino)-valeronitrile and method for producing same | |
| EP0143711A2 (fr) | Dérivés de N-(méthoxyphénacyl)-amine, utilisation notamment en thérapeutique et procédé de préparation | |
| CH637650A5 (fr) | Procede de preparation d'un acide chromone carboxylique. | |
| EP0347305B1 (fr) | [(Aryl-4-pipérazinyl-1)-2 éthoxy]-3 p-cymène, les dérivés ortho, méta, para monosubstitués ou disubstitués sur le noyau phényle dudit produit, le procédé de préparation desdits dérivés, et les médicaments contenant lesdits composés comme principe actif | |
| MC1222A1 (fr) | Nouvelles 2,4-diamino-5-benzylpyrimidines,leur preparation et leur application en tant que medicaments | |
| FR2508032A1 (fr) | Nouveaux derives amino-3 aryloxymethyl-2 propanol-1, leur procede de preparation et leurs applications en therapeutique | |
| EP0097546A1 (fr) | Benzhydrylsulfinyléthylamines, procédé de préparation et utilisation en thérapeutique | |
| EP0082059A1 (fr) | Ethers d'oximes alpha-bêta insaturés, leur procédé de préparation et leur utilisation comme médicament | |
| FR2504136A1 (fr) | (2,6-dimethoxy-4-hydroxyphenyl)-(3-piperidinopropyl)-cetone et ses sels d'addition, utilisation en therapeutique et procede de preparation | |
| EP0613470A1 (fr) | Nouveaux derives de cinnolinones-4, leur preparation et leur application en therapeutique. | |
| FR2692894A1 (fr) | Aryl-1-(o-alcoxy-phényl-4-pipérazinyl-1)-2, 3- ou 4-alcanols, leur procédé de préparation et leur utilisation pour la préparation de médicaments. | |
| CH633774A5 (en) | Phloroglucinol derivatives, their process and their application in therapeutics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |